Quickflex

Description

This formulation contains a blend of active and inactive ingredients designed for topical application. The primary component is aloe vera gel, known for its soothing properties. The formulation also includes cetyl alcohol, cetyl esters, glyceryl stearate, stearic acid, and stearyl alcohol, which serve as emulsifiers and stabilizers, contributing to the texture and consistency of the product.

Essential oils such as cinnamon oil, eucalyptus oil, peppermint oil, tea tree oil, and wintergreen oil are incorporated for their aromatic and potential therapeutic benefits. Grape seed oil and jojoba oil are included for their moisturizing properties, while squalane and vegetable glycerin enhance skin hydration.

Hypromellose acts as a thickening agent, and potassium sorbate is utilized as a preservative to maintain product integrity. Purified water serves as the solvent, ensuring the proper consistency and application of the formulation.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended dosage is to apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

The medication is intended for topical administration only. Care should be taken to ensure that the application is limited to the affected area, adhering to the specified frequency to avoid potential adverse effects.

Contraindications

Use of this product is contraindicated in patients with wounds or damaged skin. Due to the potential for irritation and adverse effects, application on such areas should be avoided. Additionally, contact with eyes or mucous membranes is contraindicated, as it may lead to significant discomfort or injury. Tight bandaging of the area where the product is applied is also not recommended, as it may exacerbate irritation or impede proper healing.

Warnings and Precautions

For external use only. This product is contraindicated for application on wounds or damaged skin.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought.

While using this product, it is crucial to avoid contact with the eyes and mucous membranes. Patients should also be instructed not to apply tight bandages over the treated area to prevent potential complications.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, medical advice should be sought.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Quickflex (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician prior to use. For children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of QUICKFLEX - menthol cream during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women who are pregnant or may become pregnant. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes in these patients.

Lactation

There is no specific information available regarding the use of QUICKFLEX - menthol cream in lactating mothers or its effects on breastfed infants. Healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse. Patients should be instructed not to apply the product on wounds or damaged skin, as this may lead to adverse effects.

Providers should inform patients to discontinue use and consult a doctor if the condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be made aware that if symptoms clear up and then recur within a few days, they should also seek medical advice.

While using this product, patients should be cautioned to avoid contact with the eyes or mucous membranes, as this may cause irritation. Furthermore, it is important to advise patients not to bandage the area tightly, as this could lead to complications.

Storage and Handling

The product is supplied in a tube that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, away from excessive heat. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients aged 2 years and older are advised to apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is recommended that a physician be consulted prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Quickflex, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)